Rare Disease: A year in review
As more investments have been made in developing and commercializing treatments for rare diseases, the experience and expertise of our CRA teams have grown....
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
For more than 50 years, we’ve delivered thoughtful, effective advice backed by research and real-world experience.
Stay informed with our latest insights.
As more investments have been made in developing and commercializing treatments for rare diseases, the experience and expertise of our CRA teams have grown....
In the fourth episode of the Canadian Bar Association’s Counterfactual Podcast, Professor Joshua Gans discusses the economics of artificial intelligence with...
Connect with us at conferences, seminars, and webinars.
Join us for our complimentary, invitation-only briefing where expert panelists will discuss recent developments, key challenges, and best practices in managing...
CRA is a proud sponsor of the event. Oliver Latham presents during the session “The Role of Experts & Approaches to Quantification of Damages.” For more...
Read our case studies to see the problems we’ve solved and results we’ve delivered.